Commentary on: Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries

被引：0
|
作者：
Juste Aristide Goungounga
Roch Giorgi
机构：
[1] Aix Marseille Univ,
[2] INSERM,undefined
[3] IRD,undefined
[4] SESSTIM,undefined
[5] Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale,undefined
[6] APHM,undefined
[7] Hôpital de la Timone,undefined
[8] Service Biostatistique et Technologies de l’Information et de la Communication,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：791 / 793
页数：2
相关论文
共 50 条
  • [21] Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group
    Sakai, Tomoyuki
    Masaki, Yasufumi
    Otsuki, Nozomi
    Sakamaki, Ippei
    Kishi, Shinji
    Miyazono, Takayoshi
    Urasaki, Yoshimasa
    Murakami, Jun
    Satoh, Tomomi
    Nakamura, Takuji
    Iwao, Haruka
    Nakajima, Akio
    Kawanami, Takafumi
    Miki, Miyuki
    Fujita, Yoshimasa
    Tanaka, Masao
    Fukushima, Toshihiro
    Okazaki, Toshiro
    Ueda, Takanori
    MEDICAL ONCOLOGY, 2015, 32 (09) : 1 - 6
  • [22] Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group
    Tomoyuki Sakai
    Yasufumi Masaki
    Nozomi Otsuki
    Ippei Sakamaki
    Shinji Kishi
    Takayoshi Miyazono
    Yoshimasa Urasaki
    Jun Murakami
    Tomomi Satoh
    Takuji Nakamura
    Haruka Iwao
    Akio Nakajima
    Takafumi Kawanami
    Miyuki Miki
    Yoshimasa Fujita
    Masao Tanaka
    Toshihiro Fukushima
    Toshiro Okazaki
    Takanori Ueda
    Medical Oncology, 2015, 32
  • [23] Kte-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study from the Descar-T Registry and Lysa Group
    Herbaux, Charles
    Bret, Caroline
    Di Blasi, Roberta
    Bachy, Emmanuel
    Beauvais, David
    Gat, Elodie
    Gastinne, Thomas
    Broussais, Florence
    Cartron, Guillaume
    Cuffel, Alexis
    Ysebaert, Loic
    Roussel, Mikael
    Bouabdallah, Krimo
    Guy, Julien
    Campidelli, Arnaud
    Van Laethem, Francois
    Casasnovas, Rene-Olivier
    Dulery, Remy
    Morschhauser, Franck
    Caillat-Zucman, Sophie
    Houot, Roch
    Le Gouill, Steven
    BLOOD, 2021, 138
  • [24] Changes in survival and time to progression in metastatic breast cancer (MBC) patients enrolled into clinical trials from 1983 to 2001.
    Gennari, A
    Conte, P
    Orlandini, C
    Guarneri, V
    Rosso, R
    Bruzzi, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 35S - 35S
  • [25] Does more intensive therapy have effects on mantle cell lymphoma? A clinical experience from the Lymphoma Treatment Study Group in Japan
    Miura, Katsuhiro
    Takasaki, Hirotaka
    Tsujimura, Hideki
    Kanno, Masatoshi
    Maeda, Yoshinobu
    Tomita, Naoto
    Takai, Kazue
    Masaki, Yasufumi
    Takizawa, Jun
    Mori, Hiraku
    Terasaki, Yasushi
    Yoshida, Takashi
    Takeuchi, Jin
    Motomura, Shigeki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (05) : 684 - 686
  • [26] Does more intensive therapy have effects on mantle cell lymphoma? A clinical experience from the Lymphoma Treatment Study Group in Japan
    Katsuhiro Miura
    Hirotaka Takasaki
    Hideki Tsujimura
    Masatoshi Kanno
    Yoshinobu Maeda
    Naoto Tomita
    Kazue Takai
    Yasufumi Masaki
    Jun Takizawa
    Hiraku Mori
    Yasushi Terasaki
    Takashi Yoshida
    Jin Takeuchi
    Shigeki Motomura
    International Journal of Hematology, 2011, 93 : 684 - 686
  • [27] Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers
    Hueso, Thomas
    Gastinne, Thomas
    Garciaz, Sylvain
    Tchernonog, Emmanuelle
    Delette, Caroline
    Casasnovas, Rene-Olivier
    Durot, Eric
    Houot, Roch
    Tessoulin, Benoit
    Tournilhac, Olivier
    Malak, Sandra
    Gyan, Emmanuel
    Fornecker, Luc-Matthieu
    Abraham, Julie
    Delapierre, Baptiste
    Peyrade, Frederic
    Lemal, Richard
    Gressin, Remy
    Chantepie, Sylvain
    Borel, Cecile
    Morello, Remy
    Bouabdallah, Krimo
    Ibrahim, Ahmad
    Bouabdallah, Reda
    Le Gouill, Steven
    Damaj, Gandhi
    BONE MARROW TRANSPLANTATION, 2020, 55 (06) : 1076 - 1084
  • [28] Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers
    Thomas Hueso
    Thomas Gastinne
    Sylvain Garciaz
    Emmanuelle Tchernonog
    Caroline Delette
    René-Olivier Casasnovas
    Eric Durot
    Roch Houot
    Benoît Tessoulin
    Olivier Tournilhac
    Sandra Malak
    Emmanuel Gyan
    Luc-Matthieu Fornecker
    Julie Abraham
    Baptiste Delapierre
    Frédéric Peyrade
    Richard Lemal
    Rémy Gressin
    Sylvain Chantepie
    Cécile Borel
    Rémy Morello
    Krimo Bouabdallah
    Ahmad Ibrahim
    Reda Bouabdallah
    Steven Le Gouill
    Gandhi Damaj
    Bone Marrow Transplantation, 2020, 55 : 1076 - 1084
  • [29] Application of the mantle international prognostic index (MIPI) to patients with mantle cell lymphoma treated with fludarabine/cyclophosphamide: Results from a UK NCRI Lymphoma Group study
    Rule, S.
    Smith, P.
    Qian, W.
    Gambell, J.
    Curtis, N.
    Johnson, P.
    Linch, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] KTE-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study From the DESCAR-T Registry and LYSA Group
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (02) : 15 - 16
12345